Concepedia

Matthew Adlam

MA

Statistics

Publications

10

Citations

861

H-Index

10

Active since

1996

Affiliations

Columbia University(Current)

Amgen (United States)

Matthew Adlam is an author at Columbia University specializing in molecular biology, life sciences, and gene expression.

Publications per year

1996–2016

10

Publications

10

Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function

Sheng Wang, Niharika Nath, Matthew Adlam et al. · Oncogene · 1999 · 236 citations

Medicine, Cancer Biology, Molecular Biology +11

Overexpression of the Helix–Loop–Helix protein Id2 blocks T cell development at multiple stages

Maureen A. Morrow, Elizabeth W. Mayer, Cesar A. Perez et al. · Molecular Immunology · 1999 · 135 citations

Life Sciences, Cell Biology, Molecular Biology +8

mTORC2 Responds to Glutamine Catabolite Levels to Modulate the Hexosamine Biosynthesis Enzyme GFAT1

Joseph G. Moloughney, Peter K. Kim, Nicole M. Vega-Cotto et al. · Molecular Cell · 2016 · 126 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +14

Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents

Roland W. Bürli, Han Xu, Xiaoming Zou et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 125 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Analysis of the kinetics of osteoclastogenesis in arthritic rats

Georg Schett, Marina Stolina, Brad Bolon et al. · Arthritis & Rheumatism · 2005 · 61 citations

Medicine, Immunology, Pathobiology +14

1–5 of 10